These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13947411)

  • 1. Evidence that the loss of brain catecholamine stores due to blockade of storage does not cause sedation.
    GESSA GL; COSTA E; KUNTZMAN R; BRODIE BB
    Life Sci (1962); 1962 Nov; 1():605-16. PubMed ID: 13947411
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence that the loss of brain catecholamine stores due to blockade of storage does not cause sedation.
    GESSA GL; COSTA E; KUNTZMAN R; BRODIE BB
    Life Sci (1962); 1962 Sep; 1():441-52. PubMed ID: 13947410
    [No Abstract]   [Full Text] [Related]  

  • 3. Is reserpine tranquilization linked to change in brain serotonin or brain norepinephrine?
    SULSER F; BRODIE BB
    Science; 1960 May; 131(3411):1440-1. PubMed ID: 13835663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INFLUENCE OF METHYLDOPA ON CENTRAL EFFECTS OF RESERPINE.
    BENFEY BG; VARMA DR
    Br J Pharmacol Chemother; 1964 Apr; 22(2):366-70. PubMed ID: 14190471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CORRELATION BETWEEN BRAIN CATECHOLAMINE AND SEDATIVE ACTION OF RESERPINE.
    MATSUOKA M; YOSHIDA H; IMAIZUMI R
    Nature; 1964 Apr; 202():198. PubMed ID: 14159603
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence that tranquilizing action of reserpine is associated with change in brain serotonin and not in brain norepinephrine.
    BRODIE BB; FINGER KF; ORLANS FB; QUINN GP; SULSER F
    J Pharmacol Exp Ther; 1960 Jul; 129():250-6. PubMed ID: 13804622
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the metabolism of 5-hydroxytryptamine (serotonin). V. Reserpine-induced sedation without depletion of cerebral 5-hydroxytryptamine.
    Gál EM; Millard SA
    Life Sci; 1967 Dec; 6(23):2505-13. PubMed ID: 4865930
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced alterations of the sub-cellular distribution of 5-hydroxytryptamine (serotonin) in rat's brain.
    GIARMAN NJ; SCHANBERG SM
    Biochem Pharmacol; 1962 Aug; 9():93-6. PubMed ID: 13947638
    [No Abstract]   [Full Text] [Related]  

  • 9. The relevancy of changes in cerebral 5-hydroxytryptamine to reserpine-produced sedation.
    Gál EM; Millard SA
    Biochem Pharmacol; 1968 Oct; 17(10):2193-203. PubMed ID: 5696885
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral branched-chain amino acid supplements that reduce brain serotonin during exercise in rats also lower brain catecholamines.
    Choi S; Disilvio B; Fernstrom MH; Fernstrom JD
    Amino Acids; 2013 Nov; 45(5):1133-42. PubMed ID: 23904096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tyrosine on brain catecholamine turnover in reserpine-treated rats.
    Oishi T; Wurtman RJ
    J Neural Transm; 1982; 53(2-3):101-8. PubMed ID: 7077311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between sedation and body temperature in the mouse.
    LESSIN AW; PARKES MW
    Br J Pharmacol Chemother; 1957 Jun; 12(2):245-50. PubMed ID: 13446381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of reserpine, alpha-methyltyrosine, and L-3,4-dihydroxyphenylalanine on brain tyrosine transaminase.
    Gibb JW; Webb JG
    Proc Natl Acad Sci U S A; 1969 Jun; 63(2):364-9. PubMed ID: 4389816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reserpine + glutethimide as premedication].
    ARNEDO GUTIERREZ JA
    Sem Med; 1958 Dec; 113(23):1055 passim. PubMed ID: 13646823
    [No Abstract]   [Full Text] [Related]  

  • 16. SEROTONIN DEFICIENCY IN INFANCY AS ONE CAUSE OF A MENTAL DEFECT IN PHENYLKETONURIA.
    WOOLLEY DW; VANDERHOEVEN T
    Science; 1964 May; 144(3620):883-4. PubMed ID: 14149409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of reserpine and tetrabenazine on catecholamine and ATP storage in cultured bovine adrenal medullary chromaffin cells.
    Caughey B; Kirshner N
    J Neurochem; 1987 Aug; 49(2):563-73. PubMed ID: 3598586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular localization of brain monoamines.
    CARLSSON A; FALCK B; HILLARP NA
    Acta Physiol Scand Suppl; 1962; 56(196):1-28. PubMed ID: 14018711
    [No Abstract]   [Full Text] [Related]  

  • 19. AWAKENING FROM RESERPINE SEDATION BY ALPHA-METHYLDOPA.
    DAY MD; RAND MJ
    J Pharm Pharmacol; 1963 Sep; 15():631-2. PubMed ID: 14059614
    [No Abstract]   [Full Text] [Related]  

  • 20. The sedative and lethal actions of reserpine in mice, as modified by 5-hydroxytryptophan, 3,4-dihydroxyphenylalanine, methylphenidate, and nikethamide in cold and warm environments.
    AIRAKSINEN MM; MATTILA M
    Acta Pharmacol Toxicol (Copenh); 1962; 19():199-204. PubMed ID: 14011421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.